Paediatric compounding and formulations in Canada: A primer for prescribers and call to action for government

Most medications are developed and manufactured with adult needs in mind. When no commercially available medication formulation is suitable to meet a child's needs, an adult medication must be manipulated to facilitate safe and appropriate administration. This process is known as compounding and is a common practice in paediatric medicine. Reliance on compounding to meet the needs of paediatric patients means that prescribers caring for children must be aware of this practice along with its intrinsic, associated risks. In parallel, there is an urgent need for Health Canada, health technology assessment bodies, provincial/territorial formulary managers, and pharmaceutical manufacturers to work together to address the complex issues that compromise access to commercially available, child-friendly formulations in Canada.

Authors

Institutions

Publication Details

Journal
Paediatrics & Child Health
Published
2025-10-17
DOI
https://doi.org/10.1093/pch/pxaf098
Primary Topic
Pharmaceutical studies and practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Paediatric compounding and formulations in Canada: A primer for prescribers and call to action for government

Geert ‘t Jong, Catherine Litalien, Derek McCreath, Charlotte Moore Hepburn
Paediatrics & Child Health
Pharmaceutical studies and practices
article

Paediatric compounding and formulations in Canada: A primer for prescribers and call to action for government

Geert ‘t Jong, Catherine Litalien, Derek McCreath, Charlotte Moore Hepburn
article en

Abstract

Most medications are developed and manufactured with adult needs in mind. When no commercially available medication formulation is suitable to meet a child's needs, an adult medication must be manipulated to facilitate safe and appropriate administration. This process is known as compounding and is a common practice in paediatric medicine. Reliance on compounding to meet the needs of paediatric patients means that prescribers caring for children must be aware of this practice along with its intrinsic, associated risks. In parallel, there is an urgent need for Health Canada, health technology assessment bodies, provincial/territorial formulary managers, and pharmaceutical manufacturers to work together to address the complex issues that compromise access to commercially available, child-friendly formulations in Canada.

Paediatrics & Child HealthVol. 31(2)
Canadian Paediatric Society (CA)
Partnerships for the goals
Openalex Percentile: Top 15%
Pharmaceutical studies and practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.